A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK
Year of publication: |
2007
|
---|---|
Authors: | Home, Philip ; Bagust, Adrian ; Taylor, Matthew ; Ambery, Philip ; Mendes da Costa, Samara |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 25.2007, 9, p. 801-802
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Cost-effectiveness | Cost-utility | Pioglitazone | Rosiglitazone | Type-2-diabetes-mellitus |
Saved in:
Online Resource
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
Persistent link: https://www.econbiz.de/10005590524